The ongoing Democratic Republic of Congo outbreak, declared in May 2026 and now exceeding 8,700 confirmed cases with a 48% fatality rate, drives market sentiment as the epicenter in Ituri and North Kivu provinces continues rapid transmission without approved vaccines for this Bundibugyo strain. Recent imported cases in Kenya (early October, with no further spread after extensive contact tracing) and earlier detections in Uganda (20 cases, outbreak declared over in August) and France highlight cross-border risks, while evacuations to Europe underscore global surveillance. Traders watch for new exports to neighbors or distant markets amid high community deaths and contact follow-up gaps, with resolution hinging on whether additional countries report confirmed cases before year-end.